WIPO's 26th Standing Committee On Patents: India Against Evergreening Of Patents

SR
S.S. Rana & Co. Advocates

Contributor

S.S. Rana & Co. is a Full-Service Law Firm with an emphasis on IPR, having its corporate office in New Delhi and branch offices in Mumbai, Bangalore, Chennai, Chandigarh, and Kolkata. The Firm is dedicated to its vision of proactively assisting its Fortune 500 clients worldwide as well as grassroot innovators, with highest quality legal services.
India is under pressure from pharmaceutical corporations backed by US and other developed nations to make more and more concessions, such as extending the term of patent beyond 20 years...
India Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

The Standing Committee on the Law of Patents under World Intellectual Property Organization (hereinafter referred to as the 'WIPO') was created in 1998 to serve as a forum to discuss issues, facilitate coordination and provide guidance concerning the progressive International Development of Patent Law.

Speaking at the 26th Standing Committee on the Law of Patents, Sumit Seth, First Secretary, WIPO, while aligning itself with the Asia Pacific Group Statement delivered by Indonesia said that the Indian Delegation are of the view that harmonizing patent laws across countries having vast differences in economy, industrial and scientific development only creates concentration of IP assets with certain regions which does not help Developing and the Least Developing Countries.

The Indian delegation also said it is against granting patents to insignificant improvements, stating in brief that, "the fundamental objective of Patent office should be rightful grants and improving the quality of the Patenting System as a whole which infuses the protection of public interest by filtering out frivolous patents." He further added that, "Ever-greening policies for patenting incremental innovations without substantial improvement would have adverse impact on delivery of healthcare services".

India is under pressure from pharmaceutical corporations backed by US and other developed nations to make more and more concessions, such as extending the term of patent beyond 20 years and lowering the standards for granting patents.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More